Skip to content
Cryptos: 636Market Cap: $2.95T 0.2%24h Vol: $129.99BDominance: BTC 44.0% ETH 7.5%
Open Tradzy

New high · Brazil stocks

Eli Lilly and Company (LILY34) closes at a 52-week high of BRL 276.31

Its fourth new 52-week high in 5 sessions. Up 30.1% over 20 sessions.

Published 16 November 2026 · Written from Tradzy's price and volume data

Close
BRL 276.31
On the day
+1.5%
Volume
no average yet
vs 52-week high
New high

Eli Lilly and Company closing prices

BRL 200.00BRL 250.00Jul '26Aug '26Aug '26Sep '26Oct '26Nov '26BRL 276.31

The last 90 closes up to 16 November 2026. The live chart is on the LILY34 page.

What happened

Eli Lilly and Company (LILY34) closed at BRL 276.31 on 16 November 2026, up 1.5% from BRL 272.15 the session before.

It was the third higher close in a row. It is the fourth new high in the last 5 sessions. Over 5 sessions the price is up 6.0%, and over 20 sessions it is up 30.1%.

That close is above every close of the past year. The previous highest was BRL 272.15 on 13 Nov 2026, and the new close is 1.5% above it.

Across the 13 B3 stocks we track, 7 closed higher and 6 closed lower that day, with a median change of +0.07%. LILY34's change was +1.5%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeBRL 272.15
CloseBRL 276.31
Change on the day+1.53%
Change over 5 sessions+6.01%
Change over 20 sessions+30.10%
Volumenot reported
Average volume, up to 20 sessions before45,557
Volume against that averagenot enough history
Highest close in the past yearBRL 272.15 (13 Nov 2026)
Lowest close in the past yearBRL 142.99 (29 Apr 2026)

The full chart and history are on Eli Lilly and Company (LILY34). More from this market: B3 news today.

More B3 moves on 16 November 2026

Want a plan for LILY34? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.